| Announce Date | 02/03/2026 |
| EPS Normalized Actual | $0 (Miss by $-0.3797) |
| EPS GAAP Actual | $0 (Miss by $-0.3797) |
| Revenue Actual | $66.2717B |
| Revenue Surprise | Beat by $66271.7M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $13.71113 |
| EPS GAAP Estimate | $13.71113 |
| Revenue Estimate | $62.401488225B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2027 | 52.96112 | 0.8 | 52.80301 | 53.11298 | 1 |
| Dec 2026 | 51.11225 | 0.82 | 51.11225 | 51.11225 | 0 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 121.1 | 108.69573 | 66.2717B | 1.47% | 12419.79M |
| FQ3 2025 (Sep 2025) | 12.2 | -0.30044 | 57.924B | 4.46% | 4331.72M |
| FQ2 2025 (Jun 2025) | 13.1 | 0.59956 | 56.3962B | 67.89% | 2803.92M |
| FQ1 2025 (Mar 2025) | 12.6 | 0.52755 | 55.4285B | 0.88% | 3639.63M |
| FQ4 2024 (Dec 2024) | 1.16 | -10.76881 | 65.2956B | 5.26% | 12060.41M |
| FQ3 2024 (Sep 2024) | 0 | -12.60051 | 55.3424B | 3.43% | 1488.54M |
| FQ2 2024 (Jun 2024) | 0.45 | -12.07172 | 18.1069B | -193.93% | 16360.59M |
| FQ1 2024 (Mar 2024) | 1.21 | 1.21 | 54.94B | 2.72% | 54940M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
13.71113
Consensus Revenue Estimates
62.401488225B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | 13.08964 | -825.16 | 13.08964 | 13.08964 | 1 |
| FQ3 2026 (Sep 2026) | 13.57472 | 10.13 | 13.57472 | 13.57472 | 1 |
| FQ2 2026 (Jun 2026) | 13.68331 | 4.26 | 13.68331 | 13.68331 | 1 |
| FQ1 2026 (Mar 2026) | 13.71113 | 8.1 | 13.71113 | 13.71113 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | 73.53B | 9.87 | 73.53B | 73.53B | 1 |
| FQ3 2026 (Sep 2026) | 62.3B | 7.03 | 62.3B | 62.3B | 1 |
| FQ2 2026 (Jun 2026) | 61.57B | 8.41 | 61.57B | 61.57B | 1 |
| FQ1 2026 (Mar 2026) | 62.4B | 11.17 | 62.4B | 62.4B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
4
EPS # of Misses
4
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 12.40427 | 121.1 | 108.69573 | 89.76% |
| FQ3 2025 (Sep 2025) | 12.50044 | 12.2 | -0.30044 | -2.46% |
| FQ2 2025 (Jun 2025) | 12.50044 | 13.1 | 0.59956 | 4.58% |
| FQ1 2025 (Mar 2025) | 12.07245 | 12.6 | 0.52755 | 4.19% |
| FQ4 2024 (Dec 2024) | 11.92881 | 1.16 | -10.76881 | -928.35% |
| FQ3 2024 (Sep 2024) | 12.60051 | 0 | -12.60051 | -INF% |
| FQ2 2024 (Jun 2024) | 12.52172 | 0.45 | -12.07172 | -2682.6% |
| FQ1 2024 (Mar 2024) | 1.21 | 1.21 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | $53.85B | $66.27B | $12419.79M | 18.74% |
| FQ3 2025 (Sep 2025) | $53.59B | $57.92B | $4331.72M | 7.48% |
| FQ2 2025 (Jun 2025) | $53.59B | $56.4B | $2803.92M | 4.97% |
| FQ1 2025 (Mar 2025) | $51.79B | $55.43B | $3639.63M | 6.57% |
| FQ4 2024 (Dec 2024) | $53.24B | $65.3B | $12060.41M | 18.47% |
| FQ3 2024 (Sep 2024) | $53.85B | $55.34B | $1488.54M | 2.69% |
| FQ2 2024 (Jun 2024) | $1.75B | $18.11B | $16360.59M | 90.36% |
| FQ1 2024 (Mar 2024) | $0B | $54.94B | $54940M | 100% |